Devroe Eric

Devroe Eric is listed in filings as Chief Operating Officer at Acrivon Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including purchase activity. Recent filings connect the profile to Acrivon Therapeutics, Inc. Common Stock (ACRV). The current snapshot covers public activity from Aug 16, 2024 to May 20, 2026. Reported amounts are shown as $1.2K to $17.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.